Physician
The Board of Trustees of the University of Illinois
The Board of Trustees of the University of Illinois was paid $11.82M by Medicaid between Jan 2018 and Feb 2023, across 300 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 36% of everything it billed.
33Billing provider infoTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
CHICAGO, IL 60612
CHICAGO, IL 60612
33aNPI1942244645assigned 06/15/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$11.82M
24GClaims739,956
24DCodes billed300
24AFirst – last monthJan 2018 – Feb 2023
Compared with peers
Next to other Cardiovascular Disease Physician providers in Illinois
Rank by total paid#1 of 678
Median peer was paid$36K
This provider vs. median327×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182,270 | $3.48M | |
| 2019 | 393,302 | $6.22M | |
| 2020 | 163,880 | $2.11M | |
| 2021 | 106 | $465.38 | |
| 2022 | 342 | $2K | |
| 2023 | 56 | $108.13 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 36% | 42,160 | 10,209 | $4.28M |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 7.9% | 14,193 | 4,443 | $934K |
| 97161 | 5.9% | 5,518 | 3,473 | $698K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.0% | 18,200 | 13,016 | $470K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.9% | 29,231 | 20,232 | $466K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.9% | 29,146 | 20,181 | $463K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2.3% | 4,776 | 1,620 | $266K |
| 97162 | 2.0% | 1,829 | 1,124 | $235K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.8% | 1,322 | 805 | $212K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.6% | 3,360 | 2,475 | $183K |
| 97535 | Self-care/home management training, each 15 minutes | 1.5% | 2,594 | 642 | $174K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 2,517 | 958 | $154K |
288 more codes
| 97116 | 1.3% | 1,905 | $154K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.2% | 19,749 | $147K |
| 86480 | <1% | 4,478 | $99K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16,309 | $97K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,786 | $94K |
| 80053 | Comprehensive metabolic panel | <1% | 28,566 | $93K |
| 87536 | <1% | 1,888 | $82K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,069 | $76K |
| 90670 | <1% | 3,308 | $76K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 770 | $73K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,109 | $73K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,234 | $67K |
| 86780 | <1% | 16,294 | $63K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 5,522 | $59K |
| 90686 | <1% | 3,703 | $58K | |
| 73562 | <1% | 2,452 | $57K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,302 | $54K |
| 87799 | <1% | 1,664 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 35,629 | $49K |
| 87653 | <1% | 2,106 | $48K | |
| 83655 | <1% | 8,786 | $46K | |
| 73630 | <1% | 2,676 | $46K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,833 | $46K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 16,357 | $45K |
| 97010 | <1% | 964 | $43K | |
| 97035 | <1% | 878 | $42K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,929 | $39K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 22,785 | $38K |
| 83970 | <1% | 2,563 | $38K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,728 | $37K |
| 73610 | <1% | 1,694 | $36K | |
| 87497 | <1% | 1,800 | $33K | |
| 73564 | <1% | 1,232 | $31K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,258 | $30K |
| 73030 | <1% | 1,613 | $28K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 10,480 | $27K |
| 73110 | <1% | 1,166 | $24K | |
| 86803 | <1% | 4,888 | $23K | |
| 85027 | <1% | 18,284 | $23K | |
| 87088 | <1% | 6,468 | $23K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,818 | $23K |
| 80061 | Lipid panel | <1% | 17,548 | $23K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 4,178 | $22K |
| 73130 | <1% | 1,280 | $22K | |
| 72110 | <1% | 714 | $21K | |
| 92523 | <1% | 196 | $21K | |
| 87340 | <1% | 7,200 | $21K | |
| 90734 | <1% | 597 | $21K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 845 | $19K |
| 74220 | <1% | 368 | $19K | |
| 72100 | <1% | 881 | $19K | |
| 87581 | <1% | 1,329 | $16K | |
| 90715 | <1% | 663 | $16K | |
| 86235 | <1% | 1,047 | $16K | |
| 87486 | <1% | 1,326 | $16K | |
| 85610 | <1% | 10,170 | $16K | |
| 72082 | <1% | 651 | $16K | |
| 81511 | <1% | 353 | $14K | |
| 80197 | <1% | 3,329 | $13K | |
| 83021 | <1% | 3,214 | $12K | |
| 87186 | <1% | 2,801 | $12K | |
| 73502 | <1% | 838 | $11K | |
| 82607 | <1% | 3,021 | $11K | |
| 80076 | <1% | 5,268 | $11K | |
| 87081 | <1% | 3,981 | $10K | |
| 86787 | <1% | 3,213 | $10K | |
| 92083 | <1% | 324 | $10K | |
| 90620 | <1% | 255 | $10K | |
| 90648 | <1% | 2,763 | $10K | |
| 84153 | <1% | 1,853 | $10K | |
| 86038 | <1% | 2,284 | $10K | |
| 90723 | <1% | 2,356 | $10K | |
| 90707 | <1% | 767 | $9K | |
| 84403 | <1% | 846 | $9K | |
| 0502F | <1% | 297 | $9K | |
| 83735 | <1% | 5,722 | $9K | |
| 82105 | <1% | 1,700 | $9K | |
| 90681 | <1% | 1,478 | $9K | |
| 97165 | <1% | 959 | $9K | |
| 84439 | <1% | 4,798 | $9K | |
| 82784 | <1% | 1,596 | $8K | |
| 81003 | <1% | 10,928 | $8K | |
| 88142 | <1% | 3,742 | $8K | |
| 82728 | <1% | 4,203 | $8K | |
| 90633 | <1% | 1,396 | $8K | |
| 83550 | <1% | 3,430 | $8K | |
| 82043 | <1% | 8,304 | $7K | |
| 86146 | <1% | 406 | $7K | |
| 83516 | <1% | 1,863 | $7K | |
| 77077 | <1% | 220 | $7K | |
| 77066 | Tomosynthesis, mammo | <1% | 105 | $7K |
| 86704 | <1% | 1,924 | $7K | |
| 73140 | <1% | 426 | $7K | |
| 86160 | <1% | 999 | $7K | |
| 87517 | <1% | 238 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 634 | $7K |
| 86850 | <1% | 4,941 | $7K | |
| 87641 | <1% | 362 | $7K | |
| 86003 | <1% | 961 | $6K | |
| 90710 | <1% | 268 | $6K | |
| 90649 | <1% | 295 | $6K | |
| 81001 | <1% | 9,178 | $6K | |
| 82570 | <1% | 5,320 | $6K | |
| 73080 | <1% | 349 | $6K | |
| 87506 | <1% | 71 | $6K | |
| 84702 | <1% | 2,048 | $6K | |
| 87338 | <1% | 643 | $6K | |
| 72050 | <1% | 234 | $6K | |
| 72040 | <1% | 331 | $6K | |
| 86901 | <1% | 4,963 | $6K | |
| 83001 | <1% | 932 | $6K | |
| 86334 | <1% | 321 | $5K | |
| 86762 | <1% | 3,349 | $5K | |
| 92250 | <1% | 180 | $5K | |
| 87102 | <1% | 3,240 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 397 | $5K |
| 82962 | <1% | 7,880 | $5K | |
| 83540 | <1% | 4,020 | $5K | |
| 84100 | <1% | 4,267 | $5K | |
| 81025 | <1% | 4,203 | $5K | |
| 82746 | <1% | 1,599 | $4K | |
| 87205 | <1% | 5,103 | $4K | |
| 88304 | <1% | 110 | $4K | |
| 86361 | <1% | 1,439 | $4K | |
| 83880 | <1% | 499 | $4K | |
| 86147 | <1% | 446 | $4K | |
| 86829 | <1% | 369 | $4K | |
| 86900 | <1% | 4,954 | $4K | |
| 86665 | <1% | 382 | $4K | |
| 74246 | <1% | 36 | $3K | |
| 84146 | <1% | 1,128 | $3K | |
| 81596 | <1% | 137 | $3K | |
| 86140 | <1% | 3,445 | $3K | |
| 90696 | <1% | 299 | $3K | |
| 92134 | <1% | 353 | $3K | |
| 86336 | <1% | 327 | $3K | |
| 86708 | <1% | 1,294 | $3K | |
| 96900 | <1% | 200 | $3K | |
| 82950 | <1% | 2,460 | $3K | |
| 84156 | <1% | 5,527 | $3K | |
| 73560 | <1% | 135 | $3K | |
| 97166 | <1% | 242 | $3K | |
| 86317 | <1% | 1,821 | $3K | |
| 83615 | <1% | 2,022 | $2K | |
| 87077 | <1% | 2,203 | $2K | |
| 88342 | <1% | 54 | $2K | |
| 83520 | <1% | 471 | $2K | |
| 84165 | <1% | 579 | $2K | |
| 92524 | <1% | 38 | $2K | |
| 85652 | <1% | 4,122 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 82 | $2K |
| 73521 | <1% | 192 | $2K | |
| 85598 | <1% | 278 | $2K | |
| 85730 | <1% | 1,811 | $2K | |
| 90698 | <1% | 77 | $2K | |
| 87902 | <1% | 22 | $2K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 107 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 604 | $2K |
| 86694 | <1% | 553 | $2K | |
| 86920 | <1% | 220 | $2K | |
| 86225 | <1% | 757 | $2K | |
| 80069 | <1% | 727 | $2K | |
| 90702 | <1% | 383 | $2K | |
| 86359 | <1% | 883 | $2K | |
| 73590 | <1% | 141 | $2K | |
| 86735 | <1% | 577 | $2K | |
| 87147 | <1% | 747 | $2K | |
| 92567 | <1% | 95 | $2K | |
| 84550 | <1% | 1,579 | $2K | |
| 83883 | <1% | 272 | $1K | |
| 86705 | <1% | 473 | $1K | |
| 96415 | <1% | 97 | $1K | |
| 86200 | <1% | 524 | $1K | |
| 82248 | <1% | 1,700 | $1K | |
| 83690 | <1% | 737 | $1K | |
| 84270 | <1% | 376 | $1K | |
| 82670 | <1% | 523 | $1K | |
| 92133 | <1% | 195 | $1K | |
| 86593 | <1% | 1,508 | $1K | |
| 90685 | <1% | 270 | $1K | |
| 87070 | <1% | 763 | $1K | |
| 73090 | <1% | 93 | $1K | |
| 96127 | <1% | 92 | $1K | |
| 82977 | <1% | 1,370 | $1K | |
| 85045 | <1% | 1,939 | $1K | |
| 86431 | <1% | 760 | $1K | |
| 86357 | <1% | 112 | $1K | |
| 86039 | <1% | 420 | $1K | |
| 84681 | <1% | 323 | $1K | |
| 82951 | <1% | 192 | $1K | |
| 70355 | <1% | 94 | $1K | |
| 86664 | <1% | 295 | $1K | |
| 86663 | <1% | 324 | $1K | |
| 82652 | <1% | 212 | $1K | |
| 86355 | <1% | 112 | $1K | |
| 86360 | <1% | 344 | $959.92 | |
| 86765 | <1% | 603 | $942.10 | |
| 83002 | <1% | 478 | $938.98 | |
| 82785 | <1% | 536 | $904.24 | |
| 86902 | <1% | 111 | $896.44 | |
| 88720 | <1% | 431 | $881.54 | |
| 86376 | <1% | 400 | $867.00 | |
| 82677 | <1% | 315 | $851.71 | |
| 73620 | <1% | 92 | $780.48 | |
| 82565 | <1% | 502 | $778.94 | |
| 87210 | <1% | 1,168 | $759.28 | |
| 82378 | <1% | 120 | $744.65 | |
| 85018 | <1% | 1,411 | $739.41 | |
| 84460 | <1% | 799 | $701.94 | |
| 86644 | <1% | 274 | $694.78 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 82 | $693.48 |
| 82103 | <1% | 272 | $678.11 | |
| 0500F | <1% | 38 | $617.40 | |
| 92557 | <1% | 14 | $615.74 | |
| 73100 | <1% | 25 | $604.51 | |
| 73120 | <1% | 30 | $603.76 | |
| 86800 | <1% | 254 | $569.06 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,345 | $536.00 |
| 86769 | <1% | 17 | $517.51 | |
| 82550 | <1% | 360 | $504.24 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27 | $501.16 |
| 80164 | <1% | 119 | $484.52 | |
| 84480 | <1% | 234 | $484.38 | |
| 86709 | <1% | 448 | $481.35 | |
| 83921 | <1% | 148 | $478.97 | |
| 84450 | <1% | 567 | $457.62 | |
| 86335 | <1% | 37 | $444.99 | |
| 87075 | <1% | 93 | $416.40 | |
| 84481 | <1% | 187 | $409.14 | |
| 74018 | <1% | 40 | $403.12 | |
| 82088 | <1% | 21 | $390.90 | |
| 84154 | <1% | 96 | $384.21 | |
| 82139 | <1% | 69 | $382.49 | |
| 82270 | <1% | 316 | $377.22 | |
| 84160 | <1% | 655 | $376.90 | |
| 82040 | <1% | 486 | $370.83 | |
| 86318 | <1% | 110 | $370.36 | |
| 82150 | <1% | 212 | $357.40 | |
| 86255 | <1% | 84 | $353.04 | |
| 82164 | <1% | 223 | $348.98 | |
| 84436 | <1% | 237 | $341.80 | |
| 85379 | <1% | 165 | $338.30 | |
| 84445 | <1% | 18 | $335.20 | |
| 86592 | <1% | 529 | $331.65 | |
| 87254 | <1% | 151 | $323.21 | |
| 82533 | <1% | 79 | $315.42 | |
| 84630 | <1% | 130 | $309.54 | |
| 96160 | <1% | 25 | $306.60 | |
| 87106 | <1% | 618 | $302.75 | |
| 77072 | <1% | 22 | $294.91 | |
| 84030 | <1% | 110 | $284.75 | |
| 82247 | <1% | 176 | $277.80 | |
| 87493 | <1% | 17 | $270.58 | |
| 86256 | <1% | 61 | $244.51 | |
| 84425 | <1% | 87 | $243.52 | |
| 82390 | <1% | 113 | $241.72 | |
| 85014 | <1% | 680 | $236.63 | |
| 82136 | <1% | 41 | $225.48 | |
| 84134 | <1% | 164 | $225.41 | |
| 84305 | <1% | 65 | $220.99 | |
| 70350 | <1% | 38 | $184.36 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $183.00 |
| 82024 | <1% | 18 | $175.44 | |
| 82330 | <1% | 51 | $170.44 | |
| 82104 | <1% | 82 | $167.34 | |
| 82627 | <1% | 109 | $156.39 | |
| 90700 | <1% | 27 | $144.99 | |
| 87040 | <1% | 22 | $144.72 | |
| 72170 | <1% | 17 | $136.62 | |
| 80177 | <1% | 43 | $132.19 | |
| 82525 | <1% | 43 | $124.20 | |
| 83090 | <1% | 51 | $122.70 | |
| 83718 | <1% | 39 | $121.66 | |
| 83498 | <1% | 46 | $108.35 | |
| 99173 | <1% | 17 | $104.30 | |
| 82947 | <1% | 177 | $95.73 | |
| 82465 | <1% | 103 | $95.00 | |
| 82952 | <1% | 107 | $91.64 | |
| 80178 | <1% | 39 | $75.57 | |
| 84479 | <1% | 29 | $65.64 | |
| 84207 | <1% | 22 | $52.72 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 164 | $41.82 |
| 85613 | <1% | 40 | $41.04 | |
| 85384 | <1% | 21 | $38.40 | |
| 36416 | <1% | 19 | $36.68 | |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 28 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 22 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZENN, MICHAEL (CHIEF FINANCIAL OFFICER)
Parent organizationTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS